Fukuoka REIT (TSE:8968) FY Earnings Cloud Its Income Appeal

Simply Wall St · 2d ago

Fukuoka REIT entered this FY 2026 earnings release with a stock that has drifted, up less than 1% over the past week but down over the past month and quarter. The REIT has a reputation as a dependable cash generator, yet the fresh numbers highlight a pressure point that matters more than headline profit.

The key story is balance sheet strain. Debt is not well covered by operating cash flow, and the distribution, with a 4.79% yield, leans on earnings that do not fully support it. Yesterday’s close at ¥167,000 reflects that unease more than the solid-looking earnings line.

Love Fukuoka REIT’s income profile but concerned about the balance sheet pressure behind that 4.79% yield? Check out the list of solid balance sheet and fundamentals stocks (22 results) for ideas that pair income potential with stronger financial backing.

FY 2026 Earnings Summary

  • Total Revenue (FY 2026, full year based on H1 + H2): ¥21,720 million vs. ¥19,327.252 million in the prior trailing period (up about 12%)
  • Net Income (Excl. Extra Items, FY 2026, full year based on H1 + H2): ¥7,936 million vs. ¥8,021.916 million in the prior trailing period (broadly flat, slightly lower)
  • Basic EPS (FY 2026, full year based on H1 + H2): ¥9,134.23 per unit vs. ¥9,233.51 in the prior trailing period (slight decline)
  • Funds From Operations (FFO, trailing 12 months to H1 2026): ¥9,437 million vs. ¥9,437 million in the prior trailing period (stable FFO, a key REIT cash flow yardstick)
Earnings give you one story, but if you care about what you are really paying for Fukuoka REIT, the cash flowing through the business matters more. Look at Fukuoka REIT's cash flows on their own and the stock could be a clear 25% undervalued.
TSE:8968 Trailing 12-Month Earnings & Revenue History as at Oct 2026
TSE:8968 Trailing 12-Month Earnings & Revenue History as at Oct 2026

Revenue Resilience Supports Income-Focused Bullish Story

For investors leaning toward the income angle on Fukuoka REIT, the top line does some heavy lifting. Total revenue of ¥21,720 million, compared with ¥19,327.252 million previously, points to a portfolio that can still attract and retain tenants. Funds From Operations of ¥9,437 million matching the prior period backs the idea that cash generation has not slipped. Net income and EPS are slightly lower, so this is not a growth story, but the combination of higher revenue and steady FFO gives some cover to the REIT’s yield-focused reputation.

Earnings Drift Underscores Bearish Balance Sheet Concerns

On the cautious side, the numbers keep the balance sheet worries alive rather than easing them. Management reports that debt coverage by operating cash flow is weak, and that the 4.79% distribution leans on earnings that do not fully support it. Net income excluding extra items and basic EPS both sit marginally below the prior trailing period, so profitability is not improving. With the unit price down over the past month and quarter, the market reaction lines up with a story of income appeal pressed against financial strain.

Does Fukuoka REIT’s income appeal still outweigh those balance sheet concerns in analysts’ eyes? Check the consensus price target analysis for Fukuoka REIT.

Hunt Quiet Cash Flow Stories

Fukuoka REIT shows how income appeal can coexist with balance sheet pressure. The real opportunity is finding stocks that could be undervalued before the market corrects them.

  • Company 1 - 27% below our estimate - supplies high precision photomasks that chipmakers rely on as design rules tighten and geometries shrink.
  • Company 2 - 23% below our estimate - sells grinding tools and advanced ceramics that equipment makers adopt when tolerances and thermal demands push past legacy materials.
  • Company 3 - 37% below our estimate - builds high specification air systems that facility owners install as clean rooms, data halls, and nuclear sites climb in complexity.

Those are three of them. See the full list of 13 companies trading below our fair value estimates →